LY3214996 +/- HCQ in Pancreatic Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This study is evaluating the safety and efficacy of combining the study drug LY3214996 with hydroxychloroquine sulfate (HCQ) in patients with advanced pancreatic cancer.
Epistemonikos ID: a75c94e7a6f050f7327da67cdb2d334a478d80e4
First added on: May 07, 2024